In addition, in trastuzumab-resistant JIMT-1 cell line derived xenograft mouse models, HER2-CAR-T cells penetrated into the tumor matrix and eradicated the established solid tumor, which subsequently resulted in an improved long-term survival58. Here, ERBB2 is linked to neoplasm.